News
Invitation to submitmanuscripts for a Special Issue of Pharmacological Reports:
Pharmacological Reports is inviting manuscripts for a special issue addressing "Energy metabolism in the physiology and pathology of the central nervous system", guest-edited by Dr Katarzyna Głombik (Department of ExperimentalNeuroendocrinology IF PAS) and dr hab. Katarzyna Kuter-Nowak (Department of Neuropsychopharmacology IF PAS). Detailed information is available at https://www.springer.com/journal/43440/updates/20024462
Maj Institute of Pharmacology Polish Academy of Sciences is a consortium member of the GRIEG research project
Maj
Institute of Pharmacology Polish Academy of Sciences is a consortium member of the
GRIEG research project entitled „Theranostic nanocarriers for drug delivery in
central nervous system disorders” funded under the Norwegian Financial
Mechanism 2014 – 2021. Prof. Piotr Warszyński from Jerzy Haber Institute of
Catalysis and Surface Chemistry PAS is the leader of the project. Apart from IP
PAS (Department of Experimental Neuroendocrinology, WP leader Prof. Władysław
Lasoń)), other project partners include The Henryk Niewodniczański Institute of
Nuclear Physics PAS, SINTEF AS (Trondheim)
and Oslo University Hospital. The main
project objective is to develop a new strategy to deliver neuroprotectants by
applying biocompatible theranostic nanocarriers, traceable in vivo by MRI, which can cross the blood-brain barrier without
imposing side effects on its normal function. Application of such neuroprotective
nanocarriers can be the solution for future therapies of stroke and
neurodegenerations like Alzheimer's and Parkinson's diseases.
PASIFIC Call 1
Maj Institute of Pharmacology Polish Academy of
Sciences (IP PAS) has become Host Institute for the realization of the Postdoctoral
Fellowship of Dr. Rugmani Meenambal (India), the winner of the first Call of the PASIFIC Programme,
which is co-financed from the Horizon 2020 programme in the frame of Marie Skłodowska-Curie Actions Co-funding of
regional, national and international programmes (MSCA COFUND). During 2-year postdoctoral fellowship, the
laureate will be running the interdisciplinary project “Neuroprotective properties of
theranostic lanthanide oxides nanoparticles against neurotoxin-induced cellular
models of Parkinson’s disease” (acronym
TheraLanOx). The
research will be conducted in the Department of Experimental Neuroendocrinology
IP PAS and in the Jerzy Haber Institute of Catalysis and Surface Chemistry Polish
Academy of Sciences (ICSC PAS, Supporting Institute) under the scientific
supervision of Dr. Danuta Jantas (Applicant’s Supervisor, IP PAS) and Prof. Piotr
Warszyński (Applicant’s Supporting Supervisor, ICSC PAS).
Invitation to contribute to a Special Issue of Pharmacological Reports: “The Post-COVID Era - Advances and Challenges in Pharmacology”
Pharmacological Reports is currently inviting articles
for the special issue “The Post-COVID Era - Advances and
Challenges in Pharmacology”, featuring as a lead guest editor prof. Marcin
Poręba (Department of ChemicalBiology and Bioimaging, Wroclaw University of
Science and Technology).
Detailed information is available at https://www.springer.com/journal/43440/updates/20039974
